Live Analyst Rating Changes 1652 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Judah Frommer
MS
Judah Frommer
Morgan Stanley
Wall Street Analyst
★★★☆☆
#948
on 13Foresight · ranked by our own returns
71%
Success Rate
+11.2%
Average Return
36 of 51 calls profitable · -7.9% vs benchmark
📈 Across the calls we could measure, roughly 71% of Judah Frommer's ratings turned a profit when each position was held for 1 year — averaging +11.2% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

91 Buy 36 Hold 23 Sell
Judah's Stock Coverage 51 ratings · 2026-06-22
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
ENGN
enGene Holdings
 Jun 18, 2026 SELL Buy
+481.4% avg upside
13 analysts
 — ·
INCY
Incyte
 Jun 15, 2026 HOLD Buy
+1.5% avg upside
47 analysts
$103.00
4.84% Upside
 -2.9%
EVMN
Evommune, Inc.
 Jun 12, 2026 BUY Strong Buy
+134.5% avg upside
12 analysts
$55.00
157.42% Upside
 +1.1%
CLDX
Celldex
 Jun 12, 2026 BUY Strong Buy
+20.6% avg upside
28 analysts
$44.00
35.76% Upside
 +3.7%
KYMR
Kymera Therapeutics
 Jun 09, 2026 BUY Strong Buy
+8.9% avg upside
36 analysts
$119.00
31.66% Upside
 +16.9%
AVLN
Avalyn Pharma Inc
 Jun 03, 2026 BUY Strong Buy
+65.3% avg upside
3 analysts
$53.00
68.47% Upside
 ·
ABVX
Abivax SA Sponsored ADR
 Jun 02, 2026 BUY Strong Buy
+20.7% avg upside
15 analysts
$132.00
33.05% Upside
 +36.8%
PROK
ProKidney
 May 18, 2026 HOLD Buy
+260.7% avg upside
12 analysts
$3.00
63.90% Upside
 ·
AGMB
AgomAb Therapeutics NV ADR
 May 18, 2026 BUY Strong Buy
+138.5% avg upside
3 analysts
$10.55
3.83% Downside
 ·
RGNX
RegenXBio
 May 15, 2026 BUY Strong Buy
+381.3% avg upside
22 analysts
$16.00
105.17% Upside
 +0.0%
ZBIO
Zenas BioPharma, Inc.
 May 14, 2026 HOLD Strong Buy
+102.2% avg upside
11 analysts
$22.00
11.28% Upside
 -1.7%
CMPS
COMPASS Pathways
 May 14, 2026 BUY Strong Buy
+63.6% avg upside
18 analysts
$17.00
35.63% Upside
 +12.4%
KLRS
Kalaris Therapeutics
 May 13, 2026 BUY Buy
+170.1% avg upside
13 analysts
$14.00
196.61% Upside
 +1.5%
BCAX
Bicara Therapeutics Inc.
 May 12, 2026 BUY Strong Buy
+34.2% avg upside
14 analysts
$37.00
59.23% Upside
 +2.4%
PTCT
PTC Therapeutics
 May 08, 2026 BUY Buy
-1.5% avg upside
29 analysts
$94.00
18.98% Upside
 +6.6%
GMAB
Genmab
 May 08, 2026 HOLD Strong Buy
+38.3% avg upside
26 analysts
$33.00
30.65% Upside
 +0.4%
ARQT
Arcutis Biotherapeutics
 May 07, 2026 BUY Strong Buy
+49.6% avg upside
14 analysts
$34.00
29.71% Upside
 +24.2%
TRVI
Trevi Therapeutics
 May 05, 2026 BUY Strong Buy
+17.4% avg upside
16 analysts
$20.00
16.17% Upside
 -3.1%
IMMX
Immix Biopharma
 Mar 26, 2026 BUY Strong Buy
+105.0% avg upside
8 analysts
$20.00
129.44% Upside
 +0.7%
FDMT
4D Molecular Therapeutics
 Mar 18, 2026 HOLD Strong Buy
+265.2% avg upside
15 analysts
 — +6.9%
LKFT
Lakefront Biotherapeutics
 Mar 16, 2026 SELL Hold
+272.4% avg upside
24 analysts
$22.00
22.22% Downside
 ·
BLTE
Belite Bio, Inc. ADR
 Mar 03, 2026 BUY Strong Buy
+25.0% avg upside
10 analysts
$201.00
37.56% Upside
 -17.7%
SRPT
Sarepta Therapeutics
 Aug 03, 2023 HOLD Buy
+244.5% avg upside
49 analysts
$139.00
692.91% Upside
 +34.1%
EFTR
eFFECTOR Therapeutics
 Jun 05, 2023 BUY Strong Buy
+66249900.0% avg upside
5 analysts
$137.50
68749900.00% Upside
 -90.6%
IMA
ImageneBio
 May 16, 2023 BUY Strong Buy
+179.7% avg upside
12 analysts
$13.00
116.59% Upside
 -77.3%
JSPR
Jasper Therapeutics
 May 15, 2023 BUY Strong Buy
+6361.2% avg upside
17 analysts
$40.00
8730.01% Upside
 +38.5%
ATAI
Atai Beckley N.V.
 May 12, 2023 BUY Strong Buy
+230.1% avg upside
16 analysts
$9.00
121.75% Upside
 -0.5%
STOK
Stoke Therapeutics
 May 05, 2023 BUY Strong Buy
+25.1% avg upside
18 analysts
$28.00
9.75% Downside
 +0.6%
NAMS
NewAmsterdam Pharma Company
 Apr 03, 2023 BUY Strong Buy
+56.4% avg upside
18 analysts
$22.00
26.20% Downside
 +63.4%
CADL
Candel Therapeutics
 Mar 31, 2023 BUY Strong Buy
+112.6% avg upside
10 analysts
$7.00
15.70% Downside
 +17.0%
ABOS
Acumen Pharmaceuticals
 Mar 28, 2023 BUY Strong Buy
+258.9% avg upside
10 analysts
$13.00
475.30% Upside
 +1.0%
FULC
Fulcrum Therapeutics
 Mar 09, 2023 HOLD Hold
+138.3% avg upside
13 analysts
$8.00
116.25% Upside
 +129.9%
ESPR
Esperion
 Mar 07, 2023 HOLD Buy
+701.2% avg upside
22 analysts
$7.00
122.26% Upside
 -53.6%
QURE
uniQure
 Feb 28, 2023 BUY Strong Buy
+20.8% avg upside
29 analysts
$55.00
18.85% Upside
 -68.1%
INSM
Insmed
 Feb 24, 2023 BUY Strong Buy
+82.2% avg upside
36 analysts
$46.00
51.96% Downside
 +35.9%
QNCX
Quince Therapeutics
 May 11, 2022 SELL Hold
+2750.2% avg upside
13 analysts
$3.50
270.26% Upside
 +47.4%
USFD
US Foods Holding
 Aug 04, 2020 BUY Strong Buy
-8.7% avg upside
22 analysts
$24.00
73.88% Downside
 +51.8%
SFM
Sprouts Farmers
 Jul 30, 2020 HOLD Buy
+8.2% avg upside
28 analysts
$26.00
67.62% Downside
 -7.2%
ACI
Albertsons Companies
 Jul 27, 2020 BUY Buy
+62.8% avg upside
24 analysts
$18.00
33.77% Upside
 +36.3%
OLLI
Ollie's Bargain Outlet Holding
 Jul 22, 2020 HOLD Strong Buy
+41.2% avg upside
27 analysts
$95.00
23.46% Upside
 -15.6%
COST
Costco
 Jul 08, 2020 HOLD Strong Buy
-9.2% avg upside
50 analysts
$328.00
65.58% Downside
 +33.2%
KR
Kroger Company
 Jun 18, 2020 HOLD Buy
+10.4% avg upside
34 analysts
$35.00
38.09% Downside
 +24.4%
FIVE
Five Below
 Jun 10, 2020 BUY Strong Buy
+13.4% avg upside
32 analysts
$116.00
40.29% Downside
 +64.1%
NL:AD
Koninklijke Ahold Delhaize N.V.
 Jun 03, 2020 HOLD Buy
-4.7% avg upside
8 analysts
$24.00
30.65% Downside
 ·
DLTR
Dollar Tree
 May 28, 2020 BUY Hold
+0.5% avg upside
35 analysts
$107.00
4.07% Downside
 -0.1%
DG
Dollar General
 May 22, 2020 HOLD Buy
+17.7% avg upside
32 analysts
$178.00
56.86% Upside
 +15.4%
BJ
Bj's Wholesale Club Holdings
 May 21, 2020 BUY Buy
+5.7% avg upside
32 analysts
$38.00
55.31% Downside
 +29.6%
SYY
Sysco
 May 05, 2020 BUY Buy
+0.2% avg upside
23 analysts
$63.00
19.90% Downside
 +68.8%
PFGC
Performance Food Group
 May 04, 2020 BUY Strong Buy
-1.6% avg upside
20 analysts
$39.00
62.33% Downside
 +107.7%
NCLH
Norwegian Cruise Line
 Mar 06, 2020 HOLD Buy
+13.6% avg upside
30 analysts
 — +6.5%
ADRNY
Koninklijke Ahold Delhaize
 Mar 06, 2019 HOLD Strong Buy
-28.5% avg upside
5 analysts
 — +4.9%
🔒 46 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Judah Frommer — Frequently Asked Questions
How accurate are Judah Frommer's stock ratings?
Based on the calls 13Foresight could measure, about 71% of Judah's ratings were profitable over a one-year hold, with an average return of +11.2% per rating, or -7.9% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Judah ranked on 13Foresight?
Judah Frommer is currently ranked #948 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Judah cover?
Judah most recently has ratings on ENGN, INCY, EVMN, CLDX, KYMR, AVLN, ABVX, PROK, AGMB, RGNX, ZBIO, CMPS and 39 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.